Philadelphia

Bucks County Firm Sells Cold-Eeze Brand for $50M

ProPhase Labs Inc. has entered into an agreement to sell its Cold-Eeze cold remedy brand to a wholly owned subsidiary of Mylan N.V. for $50 million.

The Philadelphia Business Journals first reported the Doylestown company was exploring the potential sale of the product line in August.

Under the terms of the deal, Mylan will purchase substantially all of the company's assets and other rights relating to the brand. The Cold-Eeze brand began as zinc lozenges used to shorten the duration of cold, but the formulations were later expanded to include "Gummies," quick-melts and oral spray versions of the product.

To read full article, click here.


For more business news, visit Philadelphia Business Journal.

Copyright bizjournal
Contact Us